社会功能评估作为结局指标的综述总结

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

社会功能评估作为结局指标的综述总结

Clinical Paper Summary Template Evaluation Form: Part 1

Content Analysis

1. Title of the study. Note

any acronyms or alternate

names. 在精神分裂症研究中用社会功能作为评估结局的指标

2. Key publication

information, Note

anything special about

investigators or study

sites. (e.g: reputation of

author, institution or

publication).

3. Goal of study. See Abstract

or Introduction.

4. Criteria used to select

patients. See Methods.

Evaluation Form: Part 1 (Continued)

Content Analysis (continued)

5. How the study was conducted. Note number of patients, treatment groups, and use of controls. Note any unusual features, especially those that might affect the validity of the

5. Study Design: Number of sample : 301篇 Study Design : 三次反复检索: 1, 检索词:精神分裂症合并社会功能关键词群 2, 检索词:抗精神病药合并社会功能关键词群+随即对照试验 3, 检索词:精神分裂症合并神经

6. Variables tested or measured to evaluate success or failure

of treatment. See Methods.

7. Raw data reporting study results, usually presented in numerical form, with little or no interpretation. See Results. 9. Clinical significance of results; implications for physicians and patients. See Discussions/Summary. 9. Conclusions: 在众多社会功能评估的工具中,PSP 已

发展成专业评估精神分裂症病患的功能量表,并被认为是在抗精神病药物临

Evaluation Form: Part 2 Features and Benefits Study Title:

1. List the positive qualities of

our product supported by this reprint. Identify direct quotes that can be used to support our product.

2. List the benefits to physicians or patients stemming from features highlighted in this paper.

Evaluation Form: (continued)

Strengths, Weaknesses and Possible Responses

Study Title:

3. List the strengths of the study, the factors

that

enhance its credibility to physicians

(e.g: large study size,

good design ). 3. Strengths / Positive Aspects: 本文采用系统综述的方法,所检索的资料全面。 对量表的总结和比较细致深入,特别是比较其测量学特征方面,结合结构给实际使用提供了有力的参考。 4. List the characteristics of the study

that physicians might interpret as a weakness (e.g: small study size, poor design).

5. List possible responses

to objections based on weakness (e.g: although study size is small, its findings are supported by larger trials).

相关文档
最新文档